Where Cardiology and Hepatology Converge
A multidisciplinary group advancing the science and clinical management of heart-liver interactions for practising physicians.
Office bearers
Prof. Manhal Izzy
Chair
MD · Hepatology
Madhumita Premkumar
Vice-Chair
MD DM · Hepatology
Prof. Sanjaya Satapathy
Secretary
MBBS, MD, DM, MS, FAASLD, FACG, AGAF, FASGE · Transplant Hepatology
Why this SIG, right now
The intersection of cardiac and hepatic disease presents distinct diagnostic and management challenges that neither specialty can address in isolation.
Cardiac dysfunction drives hepatic injury, and liver disease worsens cardiovascular outcomes. Clinicians need frameworks that account for both directions.
Patients with combined heart-liver conditions often fall between specialist teams. This group promotes coordinated, evidence-based care pathways.
Emerging research is reshaping how clinicians assess and treat cardio-hepatic conditions. Timely education helps practitioners apply new evidence at the bedside.
Join Cardio-Hepatic Special Interest Group to read and participate in the discussion board.
Sign In
Chair's Note
Heart and liver disease are deeply intertwined, yet clinical practice has long treated them in silos. This group exists to close that gap with rigorous, collaborative, and clinically applicable work.
The intersection of cardiac and liver disease is no longer a niche—it is a rapidly expanding clinical frontier.
From congestive hepatopathy to cirrhotic cardiomyopathy, from Fontan-associated liver disease to the cardiovascular risks embedded in metabolic liver disease, clinicians are increasingly confronted with patients whose conditions do not fit neatly within a single specialty.
Yet, our training remains siloed.
Historically, hepatologists focused on portal hypertension and liver failure, while cardiologists managed hemodynamics and cardiac function. Today, those boundaries are blurred. The same patient may require simultaneous expertise in both domains.
We now recognize that:
Heart failure can drive progressive liver injury Liver disease can profoundly alter cardiovascular physiology Shared risk factors—especially metabolic syndrome—fuel both conditions
Despite this, there remains a critical gap in structured education that integrates these disciplines into a unified clinical framework.
This is precisely why the Cardio-Hepatic Special Interest Group (SIG) was created.
Each session is designed around real-world clinical dilemmas:
How do we manage heart failure in cirrhosis? When is a patient a candidate for combined heart–liver transplantation? How do we interpret cardiac biomarkers in advanced liver disease? What is the optimal perioperative strategy in high-risk patients?
This SIG is not just about knowledge—it is about integration.
A space where hepatologists, cardiologists, transplant physicians, and internists come together to learn, discuss, and refine how we care for these complex patients.
Prof. Manhal Izzy, MD
Chair